TOCA at Banner Health

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 35 papers

  • Open Access
  • Research Article

Social support, social networks, and mental health of six refugee subgroups in Arizona: Findings from a pilot study.

  • Feb 19, 2026
  • PLOS mental health
  • Mee Young Um +9
  • Open Access
  • Research Article

The Mayo Clinic enterprise experience and outcomes of perioperative utilization of recombinant factor VIIa (rFVIIa, NovoSeven®)

  • Nov 03, 2025
  • Blood
  • Isabela Chang +5
  • Research Article

Progression of disease within 36 months (POD36) of starting first-line targeted therapy independently predicts poor overall survival in patients with chronic lymphocytic leukemia (CLL)

  • Nov 03, 2025
  • Blood
  • Paul J Hampel +22
  • Open Access
  • Research Article

CPX-351 versus venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia: A comparative analysis of outcomes in 600 patients

  • Nov 03, 2025
  • Blood
  • Saubia Fathima +28
  • Open Access
  • Research Article

Blast clearance dynamics and time to response across IDH1- and IDH2-mutated AML

  • Nov 03, 2025
  • Blood
  • Mohamad Sheikh Najeeb +19
  • Open Access
  • Research Article

Long-term rusfertide treatment in polycythemia vera: Initial results from the phase 2 THRIVE extension study

  • Nov 03, 2025
  • Blood
  • Naveen Pemmaraju +13
  • Open Access
  • Research Article
  • Citations1

Targeting lysosomes to overcome albumin-mediated proteasome inhibitor resistance in multiple myeloma

  • Nov 03, 2025
  • Blood
  • Sinto Chirackal +5
  • Research Article

Abstract B030: Health literacy and digital engagement across US Regions: Insights from the mayo clinic catchment areas

  • Sep 18, 2025
  • Cancer Epidemiology, Biomarkers & Prevention
  • Tingyu Zou +9
  • Open Access
  • Abstract
  • Citations3

OA11.06 Cemiplimab Monotherapy for First Line Advanced NSCLC Patients with PD-L1 Expression ≥50%: 5-y Outcomes of EMPOWER-Lung 1

  • Oct 01, 2024
  • Journal of Thoracic Oncology
  • S Kilickap +24
  • Open Access
  • Abstract

P4.11D.09 Fianlimab-Based Combination Therapies in Patients with Advanced Non-Small Cell Lung Cancer: Trials in Progress Updates

  • Oct 01, 2024
  • Journal of Thoracic Oncology
  • T Melkadze +15
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.